Literature DB >> 9226000

Development of laboratory and animal model systems for HIV-1 encephalitis and its associated dementia.

Y Persidsky1, H E Gendelman.   

Abstract

The neuropathogenesis of HIV-1 encephalitis and its associated dementia revolves around sustained viral replication in cells of mononuclear phagocyte origin (brain macrophages, multinucleated giant cells, and microglia). Macrophage secretory factors play important roles in facilitating monocyte trafficking into the brain, in regulating productive viral replication, and in producing neurotoxic responses. To study these events, we constructed an artificial blood-brain barrier (BBB) to assay monocyte transendothelial migration and developed an animal model system for HIV-1 encephalitis to ascertain the role that virus-infected mononuclear phagocytes play in disease pathogenesis. The BBB model was composed of brain microvascular endothelial cells and astrocytes placed on opposite sides of a porous membrane. Monocyte activation, not HIV-1 infection per se, was the central event affecting monocyte BBB migration. Many of the pathological features of HIV-1 encephalitis were reproduced in SCID mice stereotactically inoculated with virus-infected monocytes. These included widespread astrogliosis, apoptosis of neurons, dendritic damage, and macrophage/microglial activation. Such laboratory and animal model systems are being used to ascertain the pathogenic potential of virus-infected macrophages in brain and ways to curb such injurious effects.

Entities:  

Mesh:

Year:  1997        PMID: 9226000     DOI: 10.1002/jlb.62.1.100

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  27 in total

Review 1.  In vitro and animal models of human immunodeficiency virus infection of the central nervous system.

Authors:  Chadd E Nesbit; Stanley A Schwartz
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Characterization of an in vitro rhesus macaque blood-brain barrier.

Authors:  Andrew G MacLean; Marlene S Orandle; John MacKey; Kenneth C Williams; Xavier Alvarez; Andrew A Lackner
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

3.  MCP-3/CCL7 production by astrocytes: implications for SIV neuroinvasion and AIDS encephalitis.

Authors:  Nicole A Renner; Nathan S Ivey; Rachel K Redmann; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2011-01-29       Impact factor: 2.643

4.  Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.

Authors:  Supriya D Mahajan; Indrajit Roy; Gaixia Xu; Ken-Tye Yong; Hong Ding; Ravikumar Aalinkeel; Jessica Reynolds; Donald Sykes; Bindukumar B Nair; Elaine Y Lin; Paras N Prasad; Stanley A Schwartz
Journal:  Curr HIV Res       Date:  2010-07       Impact factor: 1.581

5.  The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.

Authors:  Xiqian Lan; Tomomi Kiyota; Richa Hanamsagar; Yunlong Huang; Scott Andrews; Hui Peng; Jialin C Zheng; Susan Swindells; George A Carlson; Tsuneya Ikezu
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

6.  Isolation and molecular characterization of brain microvascular endothelial cells from human brain tumors.

Authors:  Ronald E Unger; Jens B Oltrogge; Hagen von Briesen; Britta Engelhardt; Ulrike Woelki; Wolfgang Schlote; Rudiger Lorenz; Hansjurgen Bratzke; C James Kirkpatrick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

Review 7.  Humanized mice: models for evaluating NeuroHIV and cure strategies.

Authors:  Jenna B Honeycutt; J Victor Garcia
Journal:  J Neurovirol       Date:  2017-08-22       Impact factor: 2.643

8.  Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.

Authors:  M Fiala; L Zhang; X Gan; B Sherry; D Taub; M C Graves; S Hama; D Way; M Weinand; M Witte; D Lorton; Y M Kuo; A E Roher
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

9.  Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.

Authors:  Enrico Garaci; Stefano Aquaro; Caterina Lapenta; Alessandra Amendola; Massimo Spada; Sonia Covaceuszach; Carlo-Federico Perno; Filippo Belardelli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 10.  NanoART, neuroAIDS and CNS drug delivery.

Authors:  Ari Nowacek; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.